Parallax Volatility Advisers’s Clover Health Investments CLOV Stock Holding History

Parallax Volatility Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-400	Closed	-$381	–	1897
2023 Q4	$381	Hold	400	–	–	﹤0.01%	2105
2023 Q3	$432	Sell	400 -244,400	-100%	-$291K	﹤0.01%	2219
2023 Q2	$220K	Buy	244,800 +244,400	+61,100%	+$217K	﹤0.01%	1873
2023 Q1	$339	Sell	400 -400	-50%	-$438	﹤0.01%	2624
2022 Q4	$744	Buy	+800	New	+$1.07K	﹤0.01%	2759
2022 Q3	–	Sell	-1,200	Closed	-$2K	–	3090
2022 Q2	$2K	Sell	1,200 -1,771,800	-100%	-$4.71M	﹤0.01%	2768
2022 Q1	$6.29M	Buy	+1,773,000	New	+$5.14M	﹤0.01%	908

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Parallax Volatility Advisers's CLOV Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 19,855 shares — an estimated $62.5K sold.

Parallax Volatility Advisers first reported a position in CLOV in Q2 2022 and held it in 8 quarters. The position peaked at $182K in Q2 2023. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

Parallax Volatility Advisers reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
Parallax Volatility Advisers sold 19,855 Clover Health Investments shares in Q1 2025, an estimated $62.5K.
Parallax Volatility Advisers first reported a position in Clover Health Investments in Q2 2022 and held it in 8 quarters.
Parallax Volatility Advisers's Clover Health Investments position peaked at $182K in Q2 2023.
202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.